Skip to main content

UTRN

ETF

Performance overview

UTRN Price
Price Chart

Forward-looking statistics

Beta
0.67
Risk
13.97%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

The index is designed to measure the performance of a portfolio of 25 securities selected from the Solactive 500 that the index provider believes will most likely benefit from the “short-term reversal” effect, as determined by applying a proprietary algorithm. The fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in large capitalization securities issued by a U.S. company or a company economically tied to the U.S.

Fund info

The index is designed to measure the performance of a portfolio of 25 securities selected from the Solactive 500 that the index provider believes will most likely benefit from the “short-term reversal” effect, as determined by applying a proprietary algorithm. The fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in large capitalization securities issued by a U.S. company or a company economically tied to the U.S.

Investing methodPassively Managed
DiversifiedYes
Expense ratio0.75%
Asset classUnknown

Company info

Sector
Industry
Website
AUM

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)$0.05
Dividend per share
Revenue per share$4.36
Avg trading volume (30 day)$8M
Avg trading volume (10 day)$12M
Put-call ratioN/A

Macro factor sensitivity

Growth+0.7
Credit+3.1
Liquidity-0.2
Inflation-1.2
Commodities-0.2
Interest Rates-1.5

Upcoming events

Next earnings day
Next dividend day
Ex. dividend day

News

Short-Term Reversal ETF Builds Impressive Roster Of Long-Term Investors

Institutional investors have long been fans of exchange-traded funds. In fact, insurance companies, endowments and pension plans, among others, are among the biggest drivers of ETFs' ascent from obscurity to one of the world's dominant asset classes.

Benzinga (September 1, 2020)
10 ETFs Up More Than 30% in a Month

The stabilization in the spread of the disease, hopes for re-opening of the economy anytime soon, and increased progress of drugmakers' to develop COVID-19 treatment has boosted confidence in the stock market.

Zacks Investment Research (April 17, 2020)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage